

If RYBREVANT FASPRO™ or RYBREVANT® has made a difference in your life or the life of a loved one…
Consider joining the SHARE Network, a volunteer program dedicated to helping people share their health journeys to inspire others. By participating in the SHARE Network, you may have the opportunity to share your story with Johnson & Johnson employees, other patients, caregivers, or the general public. All SHARE Network activities are voluntary, and you can always decide if you would like to participate based on your own interest and availability.


We will use the information you provide to tell you more about the SHARE Network. Your information will be shared by Johnson & Johnson with their affiliates and third parties involved in the SHARE Network and for fulfillment of your optional requests. At anytime, you can request to be removed from participating in the SHARE Network and any options you selected by calling (855) 369-1305 or emailing us here. All information you provide below will be governed by our Privacy Policy. By providing your information and clicking SUBMIT, you're indicating that you have read, understand, and agree to these conditions.
Learn from Lexi, a mother of three and patient living with exon 20 insertion mutations, as she talks about how she manages treatment with RYBREVANT®.
Meet Heather, a patient living with exon 20 insertion mutations and a mother of two. Hear about her experience with RYBREVANT® and chemotherapy—and how she learned the importance of "going where the road takes her."
EGFR+ = mutated epidermal growth factor receptor; NSCLC = non-small cell lung cancer.
Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.
